Current, new and future treatments in dyslipidaemia and atherosclerosis.
about
Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric studyLaser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice.Effect of acetaminophen on atherosclerosis.A comparison of clinical outcome studies among cholesterol-lowering agents.Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc managementLipoprotein(a): an emerging cardiovascular risk factor.Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.What's new in lipid management?Beneficial Effects of Pentanema vestitum Linn. Whole Plant on the Glucose and Other Biochemical Parameters of Alloxan Induced Diabetic Rabbits.The effect of pumpkin (Cucurbita pepo L) seeds and L-arginine supplementation on serum lipid concentrations in atherogenic rats.Antidyslipidaemic activity of Glycyrrhiza glabra in high fructose diet induced dsyslipidaemic Syrian golden hamstersLipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds.The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach.Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions
P2860
Q28219359-C8AD704D-7809-4AF1-AEF7-28E165380C4CQ31038590-10264AE6-A9FD-466F-854D-59F4D013676FQ34449489-ED094294-2F8F-4BF3-9264-78F8EA6636AFQ34495746-45E5F9BE-192F-4943-8767-C5A3246F1A38Q34634698-B6783364-E977-46EB-9E34-8D2F229EC693Q35081894-596AB976-991E-4917-9A3D-9B9C91D96BAEQ35549732-F1CA0AFA-7E82-4095-82AE-8E1CFFF68F96Q35549738-0548BCEA-DB50-4713-A1D0-EBCE56EC9825Q42006414-B424764F-79CF-4958-8CDF-96221856C555Q42559400-BD2DCFCE-13E3-4213-A417-27AEA7E6DB04Q42714641-C93505E2-9125-4CE7-8982-2958C2F2198DQ46891599-CE5C9796-1F1D-4CAF-A52B-47CC041871CDQ50931633-35C0C72C-A2F9-4658-837F-58CD216D172AQ51924679-01AFDB13-2F00-44AB-AEBD-B4AF0625FFB5Q56971733-2ABBA390-7AB0-4298-AF91-934A8FD610DE
P2860
Current, new and future treatments in dyslipidaemia and atherosclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@ast
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@en
type
label
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@ast
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@en
prefLabel
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@ast
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@en
P2860
P1433
P1476
Current, new and future treatments in dyslipidaemia and atherosclerosis.
@en
P2093
Bachenheimer BS
P2860
P356
10.2165/00003495-200060010-00005
P577
2000-07-01T00:00:00Z
P6179
1004646618